EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic value of plasma %p‐tau217 in cognitively unimpaired older adults

Jesús Silva-Rodríguez, Linda Zhang, Luca Kleineidam, Francisco J López-González, Sonia Wagner-Reguero, Minerva Martínez-Castillo, Aitana Sogorb-Esteve, Michelle E Guamán-Chulunchana, Ana B Pastor, Nekane Moreno, Andrea Ruiz-Calvo, Cristina Sánchez-Martín und 17 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Jesús Silva-Rodríguez und 28 weiteren Autor:innen. Beteiligte Einrichtung: Reina Sofía Foundation Alzheimer Centre, CIEN Foundation, ISCIII, Madrid, Spain. Hauptthemen laut MEDLINE: tau Proteins, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIEN Foundation, Reina Sofía Foundation, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We evaluated the prognostic value of baseline plasma phosphorylated tau 217 ratio (%p‐tau217) for predicting long‐term progression in cognitively unimpaired (CU) older adults. METHODS We analyzed 982 community‐dwelling individuals followed annually for up to 12 years. Baseline %p‐tau217 levels were quantified by mass spectrometry and stratified into four strata using previously defined cut‐offs. Outcomes included longitudinal changes in cognition, neurodegeneration, and progression to mild cognitive impairment (MCI)/dementia. Results were replicated with immunoassays in the same and an independent primary care cohort ( n = 1204). RESULTS Participants with Elevated/High %p‐tau217 exhibited accelerated cognitive decline, hippocampal atrophy, and significantly higher risks of progression to MCI (hazard ratio [HR] > 6.0) and dementia (HR > 9.9). The Low group demonstrated a 92.2% 10‐year negative predictive value for any progression. DISCUSSION Our results suggest that %p‐tau217 is a robust prognostic biomarker, accurately distinguishing CU individuals at minimal risk from those at high risk of future AD‐related clinical and neurodegenerative decline. Similar performance was achieved by immunoassays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsCognitive DysfunctionHumansPrognosisFemaleDisease ProgressionAgedMaleBiomarkersDementiaPhosphorylationLongitudinal StudiesAged, 80 and over

Stichwörter der Autor:innen

MCIamyloidbiomarkersplasmapreclinical Alzheimer's disease

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Reina Sofía Foundation Alzheimer Centre, CIEN Foundation, ISCIII, Madrid, Spain.
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Department of Old Age Psychiatry and Cognitive Disorders, University Hospital Bonn, Bonn, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Queen Square Institute of Neurology, University College London, London, UK.
  • Nuclear Medicine Department and Molecular Imaging Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.

Förderung

  • CIEN Foundation
  • Reina Sofía Foundation
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia e Innovación
  • Hertie Network of Excellence in Clinical Neuroscience
  • European Union's Horizon Europe research and innovation programme
  • Cure Alzheimer Foundation
  • the Alzheimer Forschung Initiative

Zitieren

APA

Silva-Rodríguez, J., Zhang, L., Kleineidam, L., López-González, F. J., Wagner-Reguero, S., Martínez-Castillo, M., Sogorb-Esteve, A., Guamán-Chulunchana, M. E., Pastor, A. B., Moreno, N., Ruiz-Calvo, A., Sánchez-Martín, C., Alfayate, E., Molero-Cartón, M., Valeriano-Lorenzo, E. L., Frades-Payo, B., Valentí, M., Zea-Sevilla, M. A., Moscoso, A., …, & Sánchez-Juan, P. (2026). Prognostic value of plasma %p‐tau217 in cognitively unimpaired older adults. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71599

Vancouver

Silva-Rodríguez J, Zhang L, Kleineidam L, López-González FJ, Wagner-Reguero S, Martínez-Castillo M, et al. Prognostic value of plasma %p‐tau217 in cognitively unimpaired older adults. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71599

BibTeX
@article{SilvaRodrguez2026,
  author = {Silva-Rodríguez, Jesús and Zhang, Linda and Kleineidam, Luca and López-González, Francisco J and Wagner-Reguero, Sonia and Martínez-Castillo, Minerva and Sogorb-Esteve, Aitana and Guamán-Chulunchana, Michelle E and Pastor, Ana B and Moreno, Nekane and Ruiz-Calvo, Andrea and Sánchez-Martín, Cristina and Alfayate, Eva and Molero-Cartón, Marta and Valeriano-Lorenzo, Elizabeth L and Frades-Payo, Belén and Valentí, Meritxell and Zea-Sevilla, María A and Moscoso, Alexis and Ramírez, Alfredo and Martino-Adami, Pamela and Riedel-Heller, Steffi G and Scherer, Martin and Jeromin, Andreas and Calero, Miguel and Del Ser, Teodoro and Schneider, Anja and Grothe, Michel J and Sánchez-Juan, Pascual},
  title = {Prognostic value of plasma %p‐tau217 in cognitively unimpaired older adults},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71599}
}
Kostenlos starten →